Our Medicines

        We are a global biopharmaceutical company focused on helping to address the unmet medical needs of patients with serious diseases. In 2016, we invested $4.9 billion in R&D, which included the discovery and development of new medicines.

        Below is a list of our company's marketed products. Any linked documents and websites are intended only for U.S. residents 18 years or older, as the availability of medicines and the indications for which they are approved can vary with country and region.?

        Report Side Effects or Product Quality Complaints

        (toll free US only)

        Report Side Effects or Product Quality Complaints about Legacy Celgene Products?(ABRAXANE?,?IDHIFA?,?INREBIC?, ISTODAX?, POMALYST?, REBLOZYL?, REVLIMID?, THALOMID?, VIDAZA?)
        ?

        Learn More

        ABRAXANE? (paclitaxel protein-bound particles for injectable suspension) (albumin-bound)

        Triangle Icon

        AZACTAM? (aztreonam for injection, USP)

        Triangle Icon

        EVOTAZ? (atazanavir and cobicistat)

        Triangle Icon

        HYDREA? (hydroxyurea)

        Triangle Icon

        KENALOG?-10 (triamcinolone acetonide)

        Triangle Icon

        KENALOG? -40 (triamcinolone acetonide) and?
        KENALOG? -80 (triamcinolone acetonide)

        Triangle Icon

        PRAVACHOL? (pravastatin sodium)

        Triangle Icon

        VIDAZA? (azacitidine)

        Triangle Icon

        Legacy Brands

        ATRIPLA? (efavirenz/ emtricitabine/ tenofovir disoproxil fumarate)

        Triangle Icon

        ETOPOPHOS? (etoposide phosphate)

        Triangle Icon

        GLUCOPHAGE? (metformin hydrochloride) and?
        GLUCOPHAGE? XR (metformin hydrochloride) EXTENDED RELEASE

        Triangle Icon

        Please click below to see the Full U.S. Prescribing Information, including?Boxed WARNING?and Medication Guide/Patient Information?for:

        欧美人免费视频网站在线